Latest News in the pharma Industry
Market News
Charles River Laboratories acquires Brains On-Line
23 Aug 2017
Establishes Charles River as a premier source for CNS contract research services.
Read more
Bavarian Nordic closes transaction with Janssen Pharmaceuticals
22 Aug 2017
Collaboration grants Janssen the exclusive rights to Bavarian Nordic’s MVA-BN technology for two additional programs, targeting vaccines against hepatitis B virus and the human immunodeficiency virus.
Read more
Amgen and Humana partner for improved health outcomes and efficiency
22 Aug 2017
Partnership to target multiple serious diseases using real world data studies.
Read more.jpg)
Spray drying specialist to invest €19 million in GMP facility expansion
22 Aug 2017
Investment is in response to increased market for spray drying and capsule filling for dry powder inhalers.
Read more
Oak Therapeutics completes critical milestone in Phase I to develop oral dissolvable strip for TB
22 Aug 2017
Comapny has created a novel formulation to produce a product prototype containing 300 mg of Isoniazid, that is both rapidly dissolving and mucoadhesive.
Read more
Oxford Genetics secures £7.5 million investment
21 Aug 2017
Investment will fund a new office in Boston, US, an extension of its UK facility at the Oxford Science Park, and R&D capabilities to increase its intellectual property portfolio.
Read more
Champions Oncology collaborates with AstraZeneca to develop unique cohorts of PDX models
21 Aug 2017
Models will be used in AstraZeneca's oncology R&D programs in breast and lung cancer.
Read more
RedHill Biopharma announces US commercialization agreement for FDA-approved GI product
21 Aug 2017
Esomeprazole Strontium DR capsules 49.3 mg is an FDA-approved, proprietary, prescription proton pump inhibitor, indicated for adults for the treatment of gastroesophageal reflux disease and other gastrointestinal conditions.
Read more
Mylan finalizes settlement agreement on Medicaid rebate classification for EpiPen Auto-Injector
17 Aug 2017
Mylan will reclassify EpiPen Auto-Injector for purposes of the Medicaid Drug Rebate Program and pay the rebate applicable to innovator products effective as of 1 April 2017.
Read more
Pfizer to adopt Orion cloud platform for computational chemistry
17 Aug 2017
Orion's workflow tools will help Pfizer's efforts to deliver potential breakthrough therapies for patients.
Read more
Hikma announces new licensing agreement with Takeda for products in the MENA
17 Aug 2017
Hikma granted the exclusive rights to manufacture and commercialise three of Takeda’s leading primary care product families.
Read more
Evotec completes acquisition of Aptuit
16 Aug 2017
Employees and capabilities will be integrated into Evotec's global drug discovery group to maximise commercial synergies.
Read more